Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles

Marcela Guadalupe del Carmen, M.D.

Title
Institution
Department
Address
Phone
Fax

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Clark RM, Rice LW, Del Carmen MG. Thirty-day unplanned hospital readmission in ovarian cancer patients undergoing primary or interval cytoreductive surgery: systematic literature review. Gynecol Oncol. 2018 08; 150(2):370-377. PMID: 29929923.
    View in: PubMed
  2. Del Carmen MG, Pareja R, Melamed A, Rodriguez J, Greer A, Clark RM, Rice LW. Isolated para-aortic lymph node metastasis in FIGO stage IA2-IB2 carcinoma of the cervix: Revisiting the role of surgical assessment. Gynecol Oncol. 2018 Sep; 150(3):406-411. PMID: 30017539.
    View in: PubMed
  3. Uppal S, Spencer RJ, Rice LW, Del Carmen MG, Reynolds RK, Griggs JJ. Hospital Readmission as a Poor Measure of Quality in Ovarian Cancer Surgery. Obstet Gynecol. 2018 Jul; 132(1):126-136. PMID: 29889756.
    View in: PubMed
  4. Manning-Geist BL, Hicks-Courant K, Gockley AA, Clark RM, Del Carmen MG, Growdon WB, Horowitz NS, Berkowitz RS, Muto MG, Worley MJ. Moving beyond "complete surgical resection" and "optimal": Is low-volume residual disease another option for primary debulking surgery? Gynecol Oncol. 2018 08; 150(2):233-238. PMID: 29933927.
    View in: PubMed
  5. Del Carmen MG. Innovation in fertility-sparing oncology surgery: Traversing frontiers. Gynecol Oncol. 2018 08; 150(2):211-212. PMID: 29933929.
    View in: PubMed
  6. Del Carmen MG, Rice LW. Towards the elimination of health care disparities in gynecologic oncology: Call to action. Gynecol Oncol. 2018 04; 149(1):1-3. PMID: 29605042.
    View in: PubMed
  7. Rauh-Hain JA, Melamed A, Schaps D, Bregar AJ, Spencer R, Schorge JO, Rice LW, Del Carmen MG. Racial and ethnic disparities over time in the treatment and mortality of women with gynecological malignancies. Gynecol Oncol. 2018 04; 149(1):4-11. PMID: 29605048.
    View in: PubMed
  8. Birrer N, Chinchilla C, Del Carmen M, Dizon DS. Is Hormone Replacement Therapy Safe in Women With a BRCA Mutation?: A Systematic Review of the Contemporary Literature. Am J Clin Oncol. 2018 Mar; 41(3):313-315. PMID: 26840041.
    View in: PubMed
  9. Melamed A, Fink G, Wright AA, Keating NL, Gockley AA, Del Carmen MG, Schorge JO, Rauh-Hain JA. Effect of adoption of neoadjuvant chemotherapy for advanced ovarian cancer on all cause mortality: quasi-experimental study. BMJ. 2018 01 03; 360:j5463. PMID: 29298771.
    View in: PubMed
  10. Hinchcliff E, Melamed A, Bregar A, Diver E, Clemmer J, Del Carmen M, Schorge JO, Alejandro Rauh-Hain J. Factors associated with delivery of neoadjuvant chemotherapy in women with advanced stage ovarian cancer. Gynecol Oncol. 2018 01; 148(1):168-173. PMID: 29128105.
    View in: PubMed
  11. Pepin K, Bregar A, Davis M, Melamed A, Hinchcliff E, Gockley A, Horowitz N, Del Carmen MG. Intensive care admissions among ovarian cancer patients treated with primary debulking surgery and neoadjuvant chemotherapy-interval debulking surgery. Gynecol Oncol. 2017 12; 147(3):612-616. PMID: 28988028.
    View in: PubMed
  12. Melamed A, Manning-Geist B, Bregar AJ, Diver EJ, Goodman A, Del Carmen MG, Schorge JO, Rauh-Hain JA. Associations between residual disease and survival in epithelial ovarian cancer by histologic type. Gynecol Oncol. 2017 11; 147(2):250-256. PMID: 28822556.
    View in: PubMed
  13. Melamed A, Rizzo AE, Nitecki R, Gockley AA, Bregar AJ, Schorge JO, Del Carmen MG, Rauh-Hain JA. All-Cause Mortality After Fertility-Sparing Surgery for Stage I Epithelial Ovarian Cancer. Obstet Gynecol. 2017 07; 130(1):71-79. PMID: 28594773.
    View in: PubMed
  14. Del Carmen MG, Rice LW. Management of menopausal symptoms in women with gynecologic cancers. Gynecol Oncol. 2017 08; 146(2):427-435. PMID: 28625396.
    View in: PubMed
  15. Tanenbaum LM, Mantzavinou A, Subramanyam KS, Del Carmen MG, Cima MJ. Ovarian cancer spheroid shrinkage following continuous exposure to cisplatin is a function of spheroid diameter. Gynecol Oncol. 2017 07; 146(1):161-169. PMID: 28499648.
    View in: PubMed
  16. Melamed A, Nitecki R, Boruta DM, Del Carmen MG, Clark RM, Growdon WB, Goodman A, Schorge JO, Rauh-Hain JA. Laparoscopy Compared With Laparotomy for Debulking Ovarian Cancer After Neoadjuvant Chemotherapy. Obstet Gynecol. 2017 05; 129(5):861-869. PMID: 28383367.
    View in: PubMed
  17. Del Carmen MG, Annunziata CM, Rice LW. The clinical trials crisis in gynecologic oncology. Gynecol Oncol. 2017 06; 145(3):481-482. PMID: 28410755.
    View in: PubMed
  18. Gockley A, Melamed A, Bregar AJ, Clemmer JT, Birrer M, Schorge JO, Del Carmen MG, Rauh-Hain JA. Outcomes of Women With High-Grade and Low-Grade Advanced-Stage Serous Epithelial Ovarian Cancer. Obstet Gynecol. 2017 03; 129(3):439-447. PMID: 28178043.
    View in: PubMed
  19. Bregar AJ, Alejandro Rauh-Hain J, Spencer R, Clemmer JT, Schorge JO, Rice LW, Del Carmen MG. Disparities in receipt of care for high-grade endometrial cancer: A National Cancer Data Base analysis. Gynecol Oncol. 2017 04; 145(1):114-121. PMID: 28159409.
    View in: PubMed
  20. Bregar AJ, Melamed A, Diver E, Clemmer JT, Uppal S, Schorge JO, Rice LW, Del Carmen MG, Rauh-Hain JA. Minimally Invasive Staging Surgery in Women with Early-Stage Endometrial Cancer: Analysis of the National Cancer Data Base. Ann Surg Oncol. 2017 Jun; 24(6):1677-1687. PMID: 28074326.
    View in: PubMed
  21. Rauh-Hain JA, Melamed A, Wright A, Gockley A, Clemmer JT, Schorge JO, Del Carmen MG, Keating NL. Overall Survival Following Neoadjuvant Chemotherapy vs Primary Cytoreductive Surgery in Women With Epithelial Ovarian Cancer: Analysis of the National Cancer Database. JAMA Oncol. 2017 Jan 01; 3(1):76-82. PMID: 27892998.
    View in: PubMed
  22. Del Carmen MG, Rice LW. International Gynecologic Cancer Society (IGCS) 2016: Meeting report. Gynecol Oncol. 2017 01; 144(1):11-15. PMID: 27847107.
    View in: PubMed
  23. Dorney KM, Growdon WB, Clemmer J, Rauh-Hain JA, Hall TR, Diver E, Boruta D, Del Carmen MG, Goodman A, Schorge JO, Horowitz N, Clark RM. Patient, treatment and discharge factors associated with hospital readmission within 30days after surgery for vulvar cancer. Gynecol Oncol. 2017 Jan; 144(1):136-139. PMID: 27836203.
    View in: PubMed
  24. Bigelow CA, Horowitz NS, Goodman A, Growdon WB, Del Carmen M, Kaimal AJ. Management and outcome of cervical cancer diagnosed in pregnancy. Am J Obstet Gynecol. 2017 03; 216(3):276.e1-276.e6. PMID: 27810552.
    View in: PubMed
  25. Lax T, Dizon DS, Birrer M, Long A, Del Carmen M, Goodman A, Krasner C, Penson RT, Growdon W, Camargo CA, Banerji A. Extended carboplatin infusion does not reduce frequency of hypersensitivity reaction at initiation of retreatment in patients with recurrent platinum-sensitive ovarian cancer. J Allergy Clin Immunol Pract. 2017 Jan - Feb; 5(1):177-178. PMID: 27641482.
    View in: PubMed
  26. Melamed A, Hinchcliff EM, Clemmer JT, Bregar AJ, Uppal S, Bostock I, Schorge JO, Del Carmen MG, Rauh-Hain JA. Trends in the use of neoadjuvant chemotherapy for advanced ovarian cancer in the United States. Gynecol Oncol. 2016 Nov; 143(2):236-240. PMID: 27612977.
    View in: PubMed
  27. Melamed A, Keating NL, Clemmer JT, Bregar AJ, Wright JD, Boruta DM, Schorge JO, Del Carmen MG, Rauh-Hain JA. Laparoscopic staging for apparent stage I epithelial ovarian cancer. Am J Obstet Gynecol. 2017 Jan; 216(1):50.e1-50.e12. PMID: 27567562.
    View in: PubMed
  28. Foley OW, Rauh-Hain JA, Clark RM, Goodman A, Growdon WB, Boruta DM, Schorge JO, Del Carmen MG. Intraoperative Radiation Therapy in the Management of Gynecologic Malignancies. Am J Clin Oncol. 2016 08; 39(4):329-34. PMID: 24685883.
    View in: PubMed
  29. Del Carmen MG, Supko JG, Horick NK, Rauh-Hain JA, Clark RM, Campos SM, Krasner CN, Atkinson T, Birrer MJ. Phase 1 and 2 study of carboplatin and pralatrexate in patients with recurrent, platinum-sensitive ovarian, fallopian tube, or primary peritoneal cancer. Cancer. 2016 Nov 15; 122(21):3297-3306. PMID: 27421044.
    View in: PubMed
  30. Davis M, Aviki E, Rauh-Hain JA, Worley M, Berkowitz R, Schorge J, Muto M, Clark Sisodia R, Horowitz N, Del Carmen M. Investigating the Impact of Body Mass Index on Intraperitoneal Chemotherapy Outcomes in Ovarian and Fallopian Tube Cancer. Int J Gynecol Cancer. 2016 07; 26(6):1033-40. PMID: 27206282.
    View in: PubMed
  31. Rauh-Hain JA, Birrer M, Del Carmen MG. "Carcinosarcoma of the ovary, fallopian tube, and peritoneum: Prognostic factors and treatment modalities". Gynecol Oncol. 2016 Aug; 142(2):248-54. PMID: 27321238.
    View in: PubMed
  32. Uppal S, Del Carmen MG, Rice LW, Reynolds RK, Jolly S, Bregar A, Abdelsattar ZM, Rauh-Hain JA. Variation in care in concurrent chemotherapy administration during radiation for locally advanced cervical cancer. Gynecol Oncol. 2016 08; 142(2):286-92. PMID: 27234144.
    View in: PubMed
  33. Rauh-Hain JA, Gonzalez R, Bregar AJ, Clemmer J, Hernández-Blanquisett A, Clark RM, Schorge JO, Del Carmen MG. Patterns of care, predictors and outcomes of chemotherapy for ovarian carcinosarcoma: A National Cancer Database analysis. Gynecol Oncol. 2016 Jul; 142(1):38-43. PMID: 27107722.
    View in: PubMed
  34. Gockley AA, Rauh-Hain JA, Anders AM, Meyer LA, Clemmer J, Lu KH, Clark RM, Schorge JO, del Carmen MG. Patterns of Care, Predictors, and Outcomes of Adjuvant Therapy for Early- and Advanced-Stage Uterine Clear Cell Carcinoma: A Population-Based Analysis. Int J Gynecol Cancer. 2016 May; 26(4):697-704. PMID: 26825834.
    View in: PubMed
  35. Penson RT, Sales E, Sullivan L, Borger DR, Krasner CN, Goodman AK, del Carmen MG, Growdon WB, Schorge JO, Boruta DM, Castro CM, Dizon DS, Birrer MJ. A SNaPshot of potentially personalized care: Molecular diagnostics in gynecologic cancer. Gynecol Oncol. 2016 Apr; 141(1):108-12. PMID: 27016236.
    View in: PubMed
  36. Uppal S, Penn C, Del Carmen MG, Rauh-Hain JA, Reynolds RK, Rice LW. Readmissions after major gynecologic oncology surgery. Gynecol Oncol. 2016 05; 141(2):287-292. PMID: 26927757.
    View in: PubMed
  37. Hinchcliff EM, Esselen KM, Watkins JC, Oduyebo T, Rauh-Hain JA, Del Carmen MG, Quade BJ, Muto MG. The Role of Endometrial Biopsy in the Preoperative Detection of Uterine Leiomyosarcoma. J Minim Invasive Gynecol. 2016 May-Jun; 23(4):567-72. PMID: 26851414.
    View in: PubMed
  38. Rauh-Hain JA, Vargas RJ, Clemmer J, Clark RM, Bradford LS, Growdon WB, Goodman A, Boruta DM, Schorge JO, del Carmen MG. Mucinous Adenocarcinoma of the Endometrium Compared With Endometrioid Endometrial Cancer: A SEER Analysis. Am J Clin Oncol. 2016 Feb; 39(1):43-8. PMID: 24390270.
    View in: PubMed
  39. Bychkovsky BL, Ferreyra ME, Strasser-Weippl K, Herold CI, de Lima Lopes G, Dizon DS, Schmeler KM, Del Carmen M, Randall TC, Nogueira-Rodrigues A, de Carvalho Calabrich AF, St Louis J, Vail CM, Goss PE. Cervical cancer control in Latin America: A call to action. Cancer. 2016 Feb 15; 122(4):502-14. PMID: 26670695.
    View in: PubMed
  40. Foley OW, Birrer N, Rauh-Hain JA, Clark RM, DiTavi E, Del Carmen MG. Effect of Educational Intervention on Cervical Cancer Prevention and Screening in Hispanic Women. J Community Health. 2015 Dec; 40(6):1178-84. PMID: 26026277.
    View in: PubMed
  41. Rauh-Hain JA, Pepin KJ, Meyer LA, Clemmer JT, Lu KH, Rice LW, Uppal S, Schorge JO, Del Carmen MG. Management for Elderly Women With Advanced-Stage, High-Grade Endometrial Cancer. Obstet Gynecol. 2015 Dec; 126(6):1198-206. PMID: 26551187.
    View in: PubMed
  42. Ye H, Tanenbaum LM, Na YJ, Mantzavinou A, Fulci G, Del Carmen MG, Birrer MJ, Cima MJ. Sustained, low-dose intraperitoneal cisplatin improves treatment outcome in ovarian cancer mouse models. J Control Release. 2015 Dec 28; 220(Pt A):358-367. PMID: 26548976.
    View in: PubMed
  43. Strasser-Weippl K, Chavarri-Guerra Y, Villarreal-Garza C, Bychkovsky BL, Debiasi M, Liedke PE, Soto-Perez-de-Celis E, Dizon D, Cazap E, de Lima Lopes G, Touya D, Nunes JS, St Louis J, Vail C, Bukowski A, Ramos-Elias P, Unger-Saldaña K, Brandao DF, Ferreyra ME, Luciani S, Nogueira-Rodrigues A, de Carvalho Calabrich AF, Del Carmen MG, Rauh-Hain JA, Schmeler K, Sala R, Goss PE. Progress and remaining challenges for cancer control in Latin America and the Caribbean. Lancet Oncol. 2015 Oct; 16(14):1405-38. PMID: 26522157.
    View in: PubMed
  44. del Carmen MG. Evidence for the Relationship Between Endometriosis and Epithelial Ovarian Cancer. Obstet Gynecol Surv. 2015 Sep; 70(9):587-95. PMID: 26403563.
    View in: PubMed
  45. Aviki EM, Batalden RP, del Carmen MG, Berkowitz LR. Vacuum-Assisted Closure for Episiotomy Dehiscence. Obstet Gynecol. 2015 Sep; 126(3):530-3. PMID: 25923027.
    View in: PubMed
  46. Rauh-Hain JA, Diver E, Meyer LA, Clemmer J, Lu KH, Del Carmen MG, Schorge JO. Patterns of care, associations and outcomes of chemotherapy for uterine serous carcinoma: analysis of the National Cancer Database. Gynecol Oncol. 2015 Oct; 139(1):77-83. PMID: 26325526.
    View in: PubMed
  47. Rauh-Hain JA, Starbuck KD, Meyer LA, Clemmer J, Schorge JO, Lu KH, Del Carmen MG. Patterns of care, predictors and outcomes of chemotherapy for uterine carcinosarcoma: a National Cancer Database analysis. Gynecol Oncol. 2015 Oct; 139(1):84-9. PMID: 26307402.
    View in: PubMed
  48. Oduyebo T, Hinchcliff E, Meserve EE, Seidman MA, Quade BJ, Rauh-Hain JA, George S, Nucci MR, del Carmen MG, Muto MG. Risk Factors for Occult Uterine Sarcoma Among Women Undergoing Minimally Invasive Gynecologic Surgery. J Minim Invasive Gynecol. 2016 Jan; 23(1):34-9. PMID: 26253281.
    View in: PubMed
  49. Foley O, Dizon D, Schmeler K, Del Carmen M. Development of a Breast Cancer Advocacy and Access Health Program in Nicaragua. Breast J. 2015 Sep-Oct; 21(5):570-1. PMID: 26190769.
    View in: PubMed
  50. Rauh-Hain JA, Connor SC, Clemmer JT, Foley OW, Clark RM, Hall TR, Boruta DM, Schorge JO, del Carmen MG. Trends in Treatment of Uterine Serous Cancer in the Medicare Population. Int J Gynecol Cancer. 2015 Jul; 25(6):1023-30. PMID: 25914960.
    View in: PubMed
  51. Rauh-Hain JA, Hariton E, Clemmer J, Clark RM, Hall T, Boruta DM, Schorge JO, Del Carmen MG. Incidence and effects on mortality of venous thromboembolism in elderly women with endometrial cancer. Obstet Gynecol. 2015 Jun; 125(6):1362-70. PMID: 26000507.
    View in: PubMed
  52. Rauh-Hain JA, Buskwofie A, Clemmer J, Boruta DM, Schorge JO, del Carmen MG. Racial disparities in treatment of high-grade endometrial cancer in the Medicare population. Obstet Gynecol. 2015 Apr; 125(4):843-51. PMID: 25751197.
    View in: PubMed
  53. Joseph N, Clark RM, Dizon DS, Lee MS, Goodman A, Boruta D, Schorge JO, Del Carmen MG, Growdon WB. Delay in chemotherapy administration impacts survival in elderly patients with epithelial ovarian cancer. Gynecol Oncol. 2015 Jun; 137(3):401-5. PMID: 25839911.
    View in: PubMed
  54. del Carmen MG, Rice LW, Schmeler KM. Global health perspective on gynecologic oncology. Gynecol Oncol. 2015 May; 137(2):329-34. PMID: 25782635.
    View in: PubMed
  55. Foley OW, Rauh-Hain JA, Clemmer J, Clark RM, Hall T, Diver EJ, Schorge JO, del Carmen MG. Trends in the treatment of uterine leiomyosarcoma in the Medicare population. Int J Gynecol Cancer. 2015 Mar; 25(3):453-8. PMID: 25628107.
    View in: PubMed
  56. Sisodia RM, Del Carmen MG, Boruta DM. Role of minimally invasive surgery in the management of adnexal masses. Clin Obstet Gynecol. 2015 Mar; 58(1):66-75. PMID: 25608253.
    View in: PubMed
  57. Del Carmen MG. Adnexal pathology. Foreword. Clin Obstet Gynecol. 2015 Mar; 58(1):1-2. PMID: 25551697.
    View in: PubMed
  58. del Carmen MG, Rice LW. Underrepresentation of women in clinical trials: why gynecologic oncologists are worried. Obstet Gynecol. 2015 Mar; 125(3):616-9. PMID: 25730224.
    View in: PubMed
  59. Linkov F, Edwards RP, Althouse A, Rauh-Hain JA, Del Carmen MG, Freese KE, Kelley JL, Olawaiye AB. Obesity, lymphadenectomy and survival outcomes in intermediate to high-risk, early-stage endometrial cancer patients. Future Oncol. 2015; 11(4):607-15. PMID: 25686116.
    View in: PubMed
  60. Rauh-Hain JA, Foley OW, Winograd D, Andrade C, Clark RM, Vargas RJ, Hinchcliff EM, Esselen KM, Horowitz NS, del Carmen MG. Clinical characteristics and outcomes of patients with stage I epithelial ovarian cancer compared with fallopian tube cancer. Am J Obstet Gynecol. 2015 May; 212(5):600.e1-8. PMID: 25514761.
    View in: PubMed
  61. Clark RM, Lee MS, Alejandro Rauh-Hain J, Hall T, Boruta DM, del Carmen MG, Goodman A, Schorge JO, Growdon WB. Surgical Apgar Score and prediction of morbidity in women undergoing hysterectomy for malignancy. Gynecol Oncol. 2015 Mar; 136(3):516-20. PMID: 25475542.
    View in: PubMed
  62. Gockley AA, Rauh-Hain JA, del Carmen MG. Uterine leiomyosarcoma: a review article. Int J Gynecol Cancer. 2014 Nov; 24(9):1538-42. PMID: 25304676.
    View in: PubMed
  63. Owusu-Darko S, Rauh-Hain JA, Horowitz NS, Goodman A, Schorge JO, Del Carmen MG. Comparison of outcomes in patients with early-stage mucinous endometrial cancer and those with endometrioid endometrial cancer, with and without adjuvant therapy. J Reprod Med. 2014 Nov-Dec; 59(11-12):527-33. PMID: 25552123.
    View in: PubMed
  64. Rauh-Hain JA, Goodman A, Boruta DM, Schorge JO, Horowitz NS, del Carmen MG. Endometrial stromal sarcoma: a clinicopathologic study of 29 patients. J Reprod Med. 2014 Nov-Dec; 59(11-12):547-52. PMID: 25552126.
    View in: PubMed
  65. Rauh-Hain JA, Hinchcliff EM, Oduyebo T, Worley MJ, Andrade CA, Schorge JO, George S, Muto MG, del Carmen MG. Clinical outcomes of women with recurrent or persistent uterine leiomyosarcoma. Int J Gynecol Cancer. 2014 Oct; 24(8):1434-40. PMID: 25248114.
    View in: PubMed
  66. George S, Barysauskas C, Serrano C, Oduyebo T, Rauh-Hain JA, Del Carmen MG, Demetri GD, Muto MG. Retrospective cohort study evaluating the impact of intraperitoneal morcellation on outcomes of localized uterine leiomyosarcoma. Cancer. 2014 Oct 15; 120(20):3154-8. PMID: 24923260.
    View in: PubMed
  67. Worley MJ, Guseh SH, Rauh-Hain JA, Esselen KM, Muto MG, Feltmate CM, Berkowitz RS, Del Carmen MG, Schorge JO, Horowitz NS. What is the optimal treatment for obese patients with advanced ovarian carcinoma? Am J Obstet Gynecol. 2014 Sep; 211(3):231.e1-9. PMID: 24704062.
    View in: PubMed
  68. del Carmen MG. Positive peritoneal cytology in patients with endometrial cancer: continued controversy despite shift in staging. Cancer Cytopathol. 2014 May; 122(5):315-6. PMID: 24578288.
    View in: PubMed
  69. Rauh-Hain JA, Clemmer J, Clark RM, Bradford LS, Growdon WB, Goodman A, Boruta DM, Dizon DS, Schorge JO, del Carmen MG. Management and outcomes for elderly women with vulvar cancer over time. BJOG. 2014 May; 121(6):719-27; discussion 727. PMID: 24621118.
    View in: PubMed
  70. Vargas R, Rauh-Hain JA, Clemmer J, Clark RM, Goodman A, Growdon WB, Schorge JO, Del Carmen MG, Horowitz NS, Boruta DM. Tumor size, depth of invasion, and histologic grade as prognostic factors of lymph node involvement in endometrial cancer: a SEER analysis. Gynecol Oncol. 2014 May; 133(2):216-20. PMID: 24548726.
    View in: PubMed
  71. Guseh SH, Rauh-Hain JA, Tambouret RH, Davis M, Clark RM, Boruta DM, Goodman A, Growdon WB, Schorge JO, del Carmen MG. Transitional cell carcinoma of the ovary: a case-control study. Gynecol Oncol. 2014 Mar; 132(3):649-53. PMID: 24462804.
    View in: PubMed
  72. Davis M, Rauh-Hain JA, Andrade C, Boruta DM, Schorge JO, Horowitz NS, May T, del Carmen MG. Comparison of clinical outcomes of patients with clear cell and endometrioid ovarian cancer associated with endometriosis to papillary serous carcinoma of the ovary. Gynecol Oncol. 2014 Mar; 132(3):760-6. PMID: 24440832.
    View in: PubMed
  73. Jeudin P, Liveright E, Del Carmen MG, Perkins RB. Race, ethnicity, and income factors impacting human papillomavirus vaccination rates. Clin Ther. 2014 Jan 01; 36(1):24-37. PMID: 24417783.
    View in: PubMed
  74. Oduyebo T, Rauh-Hain AJ, Meserve EE, Seidman MA, Hinchcliff E, George S, Quade B, Nucci MR, Del Carmen MG, Muto MG. The value of re-exploration in patients with inadvertently morcellated uterine sarcoma. Gynecol Oncol. 2014 Feb; 132(2):360-5. PMID: 24296345.
    View in: PubMed
  75. Garrett LA, Growdon WB, Goodman A, Boruta DM, Schorge JO, del Carmen MG. Endometriosis-associated ovarian malignancy: a retrospective analysis of presentation, treatment, and outcome. J Reprod Med. 2013 Nov-Dec; 58(11-12):469-76. PMID: 24568040.
    View in: PubMed
  76. Rauh-Hain JA, del Carmen MG. Endometrial stromal sarcoma: a systematic review. Obstet Gynecol. 2013 Sep; 122(3):676-83. PMID: 23921879.
    View in: PubMed
  77. Rauh-Hain JA, Guseh SH, Esselen KM, Growdon WB, Schorge JO, Horowitz NS, Krasner CN, del Carmen MG, Birrer MJ, Dizon DS. Patterns of recurrence in patients treated with bevacizumab in the primary treatment of advanced epithelial ovarian cancer. Int J Gynecol Cancer. 2013 Sep; 23(7):1219-25. PMID: 23975042.
    View in: PubMed
  78. Rauh-Hain JA, Davis M, Clemmer J, Clark RM, Growdon WB, Goodman AK, Boruta DM, Schorge JO, del Carmen MG. Prognostic determinants in patients with uterine and ovarian clear cell carcinoma: a SEER analysis. Gynecol Oncol. 2013 Nov; 131(2):404-9. PMID: 24004647.
    View in: PubMed
  79. Rauh-Hain JA, Clemmer JT, Bradford LS, Clark RM, Growdon WB, Goodman A, Boruta DM, Schorge JO, del Carmen MG. Racial disparities in cervical cancer survival over time. Cancer. 2013 Oct 15; 119(20):3644-52. PMID: 23913530.
    View in: PubMed
  80. Rauh-Hain JA, Diver EJ, Clemmer JT, Bradford LS, Clark RM, Growdon WB, Goodman AK, Boruta DM, Schorge JO, del Carmen MG. Carcinosarcoma of the ovary compared to papillary serous ovarian carcinoma: a SEER analysis. Gynecol Oncol. 2013 Oct; 131(1):46-51. PMID: 23906658.
    View in: PubMed
  81. Rauh-Hain JA, Clemmer J, Clark RM, Bradford LS, Growdon WB, Goodman A, Boruta DM, Schorge JO, del Carmen MG. Racial disparities and changes in clinical characteristics and survival for vulvar cancer over time. Am J Obstet Gynecol. 2013 Nov; 209(5):468.e1-468.e10. PMID: 23891626.
    View in: PubMed
  82. Rauh-Hain JA, Shoni M, Schorge JO, Goodman A, Horowitz NS, del Carmen MG. Prognostic determinants in patients with uterine and ovarian carcinosarcoma. J Reprod Med. 2013 Jul-Aug; 58(7-8):297-304. PMID: 23947079.
    View in: PubMed
  83. Rauh-Hain JA, Oduyebo T, Diver EJ, Guseh SH, George S, Muto MG, del Carmen MG. Uterine leiomyosarcoma: an updated series. Int J Gynecol Cancer. 2013 Jul; 23(6):1036-43. PMID: 23714705.
    View in: PubMed
  84. Clark RM, Growdon WB, Wiechert A, Boruta D, Del Carmen M, Goodman AK, Bradford L, Rauh-Hain A, Schorge JO. Patient, treatment and discharge factors associated with hospital readmission within 30 days after surgical cytoreduction for epithelial ovarian carcinoma. Gynecol Oncol. 2013 Sep; 130(3):407-10. PMID: 23747329.
    View in: PubMed
  85. Jeudin P, Liveright E, del Carmen MG, Perkins RB. Race, ethnicity and income as factors for HPV vaccine acceptance and use. Hum Vaccin Immunother. 2013 Jul; 9(7):1413-20. PMID: 23571170.
    View in: PubMed
  86. Foley OW, Rauh-Hain JA, del Carmen MG. Recurrent epithelial ovarian cancer: an update on treatment. Oncology (Williston Park). 2013 Apr; 27(4):288-94, 298. PMID: 23781692.
    View in: PubMed
  87. Schmeler KM, Ramirez PT, Reyes-Martinez CA, Chernofsky MR, del Carmen MG, Diaz-Montes TP, Padilla L, Tejada-Berges T, Tarraza H, Bermudez A, Trimble EL. The Central America Gynecologic Oncology Education Program (CONEP): improving gynecologic oncology education and training on a global scale. Gynecol Oncol. 2013 Jun; 129(3):445-7. PMID: 23528927.
    View in: PubMed
  88. del Carmen MG, Avila-Wallace M. Effect of health care disparities on screening. Clin Obstet Gynecol. 2013 Mar; 56(1):65-75. PMID: 23314716.
    View in: PubMed
  89. Diver E, O'Connor O, Garrett L, Boruta D, Goodman A, Del Carmen M, Schorge J, Mueller P, Growdon W. Modest benefit of total parenteral nutrition and chemotherapy after venting gastrostomy tube placement. Gynecol Oncol. 2013 May; 129(2):332-5. PMID: 23402902.
    View in: PubMed
  90. Rauh-Hain JA, Nitschmann CC, Worley MJ, Bradford LS, Berkowitz RS, Schorge JO, Campos SM, del Carmen MG, Horowitz NS. Platinum resistance after neoadjuvant chemotherapy compared to primary surgery in patients with advanced epithelial ovarian carcinoma. Gynecol Oncol. 2013 Apr; 129(1):63-8. PMID: 23337490.
    View in: PubMed
  91. Foley OW, Rauh-Hain JA, del Carmen MG. The role of intraoperative radiation therapy in the management of recurrent and locally advanced gynecologic cancers. Int J Gynecol Cancer. 2013 Jan; 23(1):9-15. PMID: 23187790.
    View in: PubMed
  92. del Carmen MG, Birrer M, Schorge JO. Uterine papillary serous cancer: a review of the literature. Gynecol Oncol. 2012 Dec; 127(3):651-61. PMID: 23000148.
    View in: PubMed
  93. Diver EJ, Rauh-Hain JA, Del Carmen MG. Total pelvic exenteration for gynecologic malignancies. Int J Surg Oncol. 2012; 2012:693535. PMID: 22720150; PMCID: PMC3376473.
  94. del Carmen MG, Micha J, Small L, Street DG, Londhe A, McGowan T. A phase II clinical trial of pegylated liposomal doxorubicin and carboplatin plus bevacizumab in patients with platinum-sensitive recurrent ovarian, fallopian tube, or primary peritoneal cancer. Gynecol Oncol. 2012 Sep; 126(3):369-74. PMID: 22659190.
    View in: PubMed
  95. del Carmen MG, Birrer M, Schorge JO. Clear cell carcinoma of the ovary: a review of the literature. Gynecol Oncol. 2012 Sep; 126(3):481-90. PMID: 22525820.
    View in: PubMed
  96. Growdon WB, Rauh-Hain JJ, Cordon A, Garrett L, Schorge JO, Goodman A, Boruta DM, Horowitz NS, del Carmen MG. Prognostic determinants in patients with stage I uterine papillary serous carcinoma: a 15-year multi-institutional review. Int J Gynecol Cancer. 2012 Mar; 22(3):417-24. PMID: 22237383.
    View in: PubMed
  97. Rauh-Hain JA, Winograd D, Growdon WB, Schorge JO, Goodman AK, Boruta DM, Berkowitz RS, Horowitz NS, Del Carmen MG. Prognostic determinants in patients with uterine and ovarian clear carcinoma. Gynecol Oncol. 2012 May; 125(2):376-80. PMID: 22366593.
    View in: PubMed
  98. Rodriguez N, Rauh-Hain JA, Shoni M, Berkowitz RS, Muto MG, Feltmate C, Schorge JO, Del Carmen MG, Matulonis UA, Horowitz NS. Changes in serum CA-125 can predict optimal cytoreduction to no gross residual disease in patients with advanced stage ovarian cancer treated with neoadjuvant chemotherapy. Gynecol Oncol. 2012 May; 125(2):362-6. PMID: 22333992.
    View in: PubMed
  99. Spencer R, Schorge J, Del Carmen M, Goodman A, Growdon W, Boruta D. Laparoscopic surgery for endometrial cancer: why don't all patients go home the day after surgery? J Minim Invasive Gynecol. 2012 Jan-Feb; 19(1):95-100. PMID: 22196258.
    View in: PubMed
  100. del Carmen MG, Birrer M, Schorge JO. Carcinosarcoma of the ovary: a review of the literature. Gynecol Oncol. 2012 Apr; 125(1):271-7. PMID: 22155675.
    View in: PubMed
  101. Schorge JO, Bradford LS, del Carmen MG. Primary cytoreductive surgery for advanced ovarian cancer: is it the past, present, or future? Clin Adv Hematol Oncol. 2011 Dec; 9(12):912-8. PMID: 22252659.
    View in: PubMed
  102. Rauh-Hain JA, Rodriguez N, Growdon WB, Goodman AK, Boruta DM, Horowitz NS, del Carmen MG, Schorge JO. Primary debulking surgery versus neoadjuvant chemotherapy in stage IV ovarian cancer. Ann Surg Oncol. 2012 Mar; 19(3):959-65. PMID: 21994038.
    View in: PubMed
  103. Esselen KM, Boruta DM, del Carmen M, Schorge JO, Goodman A, Growdon WB. Defining prognostic variables in recurrent endometrioid endometrial cancer: a 15-year single-institution review. Int J Gynecol Cancer. 2011 Aug; 21(6):1078-83. PMID: 21633304.
    View in: PubMed
  104. Boruta DM, Growdon WB, McCann CK, Garrett LA, del Carmen MG, Goodman A, Schorge JO. Evolution of surgical management of early-stage endometrial cancer. Am J Obstet Gynecol. 2011 Dec; 205(6):565.e1-6. PMID: 21855843.
    View in: PubMed
  105. Del Carmen MG, Boruta DM, Schorge JO. Recurrent endometrial cancer. Clin Obstet Gynecol. 2011 Jun; 54(2):266-77. PMID: 21508696.
    View in: PubMed
  106. Schorge JO, Russell AH, Garrett LA, Goodman A, Del Carmen MG, Growdon WB, Boruta DM. Paradigm shift in the management of high-intermediate risk stage I endometrial cancer. J Clin Oncol. 2011 May 20; 29(15_suppl):5103. PMID: 28019907.
    View in: PubMed
  107. Del Carmen MG, Micha JP, Small LA, Street DG, Londhe A, McGowan T. Pegylated liposomal doxorubicin and carboplatin plus bevacizumab in patients with platinum sensitive recurrent ovarian, fallopian tube, or primary peritoneal cancers: Results of a phase II study. J Clin Oncol. 2011 May 20; 29(15_suppl):5061. PMID: 28023674.
    View in: PubMed
  108. McCann CK, Growdon WB, Munro EG, Del Carmen MG, Boruta DM, Schorge JO, Goodman A. Prognostic significance of splenectomy as part of initial cytoreductive surgery in ovarian cancer. Ann Surg Oncol. 2011 Oct; 18(10):2912-8. PMID: 21424880.
    View in: PubMed
  109. Rauh-Hain JA, Growdon WB, Rodriguez N, Goodman AK, Boruta DM, Schorge JO, Horowitz NS, del Carmen MG. Carcinosarcoma of the ovary: a case-control study. Gynecol Oncol. 2011 Jun 01; 121(3):477-81. PMID: 21420726.
    View in: PubMed
  110. Rauh-Hain JA, Krivak TC, Del Carmen MG, Olawaiye AB. Ovarian cancer screening and early detection in the general population. Rev Obstet Gynecol. 2011; 4(1):15-21. PMID: 21629494; PMCID: PMC3100094.
  111. Allen JD, Othus MK, Shelton RC, Li Y, Norman N, Tom L, del Carmen MG. Parental decision making about the HPV vaccine. Cancer Epidemiol Biomarkers Prev. 2010 Sep; 19(9):2187-98. PMID: 20826829.
    View in: PubMed
  112. Rauh-Hain JA, Growdon WB, Schorge JO, Goodman AK, Boruta DM, McCann C, Horowitz NS, del Carmen MG. Prognostic determinants in patients with stage IIIC and IV uterine papillary serous carcinoma. Gynecol Oncol. 2010 Nov; 119(2):299-304. PMID: 20691465.
    View in: PubMed
  113. Rauh-Hain JA, Del Carmen MG. Treatment for advanced and recurrent endometrial carcinoma: combined modalities. Oncologist. 2010; 15(8):852-61. PMID: 20660059; PMCID: PMC3228028.
  114. Chapman E, Venkat P, Ko E, Orezzoli JP, Del Carmen M, Garner EI. Use of multimedia as an educational tool to improve human papillomavirus vaccine acceptability--a pilot study. Gynecol Oncol. 2010 Aug 01; 118(2):103-7. PMID: 20457469.
    View in: PubMed
  115. Rauh-Hain JA, Olawaiye AB, Munro M, Ko E, Alarcon IA, Del Carmen MG, Duska L. Role of computed tomography in the surgical management of patients with bowel obstruction secondary to recurrent ovarian carcinoma. Ann Surg Oncol. 2010 Mar; 17(3):853-60. PMID: 20183913.
    View in: PubMed
  116. Schorge JO, McCann C, Del Carmen MG. Surgical debulking of ovarian cancer: what difference does it make? Rev Obstet Gynecol. 2010; 3(3):111-7. PMID: 21364862; PMCID: PMC3046749.
  117. Rauh-Hain JA, del Carmen M, Horowitz NS, Alarcon IA, Ko E, Goodman AK, Olawaiye AB. Impact of bowel obstruction at the time of initial presentation in women with ovarian cancer. BJOG. 2010 Jan; 117(1):32-8. PMID: 20002368.
    View in: PubMed
  118. Rauh-Hain JA, Costaaggini I, Olawaiye AB, Growdon WB, Horowitz NS, del Carmen MG. A comparison of outcome in patients with stage 1 clear cell and grade 3 endometrioid adenocarcinoma of the endometrium with and without adjuvant therapy. Eur J Gynaecol Oncol. 2010; 31(3):284-7. PMID: 21077469.
    View in: PubMed
  119. Na YJ, Farley J, Zeh A, del Carmen M, Penson R, Birrer MJ. Ovarian cancer: markers of response. Int J Gynecol Cancer. 2009 Dec; 19 Suppl 2:S21-9. PMID: 19955910.
    View in: PubMed
  120. Del Carmen MG. Mesenchymal Tumors of the Female Genital Tract: Treatment. Surg Pathol Clin. 2009 Dec; 2(4):835-48. PMID: 26838782.
    View in: PubMed
  121. de Moya MA, del Carmen MG, Allain RM, Hirschberg RE, Shepard JA, Kradin RL. Case records of the Massachusetts General Hospital. Case 33-2009. A 35-year-old woman with fever, abdominal pain, and hypotension after cesarean section. N Engl J Med. 2009 Oct 22; 361(17):1689-97. PMID: 19846855.
    View in: PubMed
  122. Watts L, Joseph N, Velazquez A, Gonzalez M, Munro E, Muzikansky A, Rauh-Hain JA, Del Carmen MG. Understanding barriers to cervical cancer screening among Hispanic women. Am J Obstet Gynecol. 2009 Aug; 201(2):199.e1-8. PMID: 19646571.
    View in: PubMed
  123. Wright K, Munro E, Del Carmen M, Goodman AK. Prognosis and comorbidities in stage III and IV endometrial cancer. J Clin Oncol. 2009 May 20; 27(15_suppl):e16553. PMID: 27960816.
    View in: PubMed
  124. Orezzoli JP, Sioletic S, Olawaiye A, Oliva E, del Carmen MG. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion. Gynecol Oncol. 2009 Jun; 113(3):316-23. PMID: 19345400.
    View in: PubMed
  125. Goldstein MA, Goodman A, del Carmen MG, Wilbur DC. Case records of the Massachusetts General Hospital. Case 10-2009. A 23-year-old woman with an abnormal Papanicolaou smear. N Engl J Med. 2009 Mar 26; 360(13):1337-44. PMID: 19321871.
    View in: PubMed
  126. Pandharipande PV, Choy G, del Carmen MG, Gazelle GS, Russell AH, Lee SI. MRI and PET/CT for triaging stage IB clinically operable cervical cancer to appropriate therapy: decision analysis to assess patient outcomes. AJR Am J Roentgenol. 2009 Mar; 192(3):802-14. PMID: 19234280.
    View in: PubMed
  127. Watts LA, Joseph N, Wallace M, Rauh-Hain JA, Muzikansky A, Growdon WB, del Carmen MG. HPV vaccine: A comparison of attitudes and behavioral perspectives between Latino and non-Latino women. Gynecol Oncol. 2009 Mar; 112(3):577-82. PMID: 19150120.
    View in: PubMed
  128. Olawaiye A, Del Carmen M, Tambouret R, Goodman A, Fuller A, Duska LR. Abdominal radical trachelectomy: Success and pitfalls in a general gynecologic oncology practice. Gynecol Oncol. 2009 Mar; 112(3):506-10. PMID: 19131094.
    View in: PubMed
  129. Olawaiye AB, Rauh-Hain JA, Withiam-Leitch M, Rueda B, Goodman A, del Carmen MG. Utility of pre-operative serum CA-125 in the management of uterine papillary serous carcinoma. Gynecol Oncol. 2008 Sep; 110(3):293-8. PMID: 18644620.
    View in: PubMed
  130. Orezzoli JP, Russell AH, Oliva E, Del Carmen MG, Eichhorn J, Fuller AF. Prognostic implication of endometriosis in clear cell carcinoma of the ovary. Gynecol Oncol. 2008 Sep; 110(3):336-44. PMID: 18639330.
    View in: PubMed
  131. Growdon WB, Del Carmen M. Human papillomavirus-related gynecologic neoplasms: screening and prevention. Rev Obstet Gynecol. 2008; 1(4):154-61. PMID: 19173019; PMCID: PMC2621053.
  132. del Carmen, MG. Primary squamous carcinoma of the uterine cervix: Diagnosis and management. Harrison's Manual of Oncology (Editors Bruce A. Chabner, Dan L. Longo, Thomas J. Lynch). 2008; 497-502.
  133. del Carmen MG, Halpern EF, Kopans DB, Moy B, Moore RH, Goss PE, Hughes KS. Mammographic breast density and race. AJR Am J Roentgenol. 2007 Apr; 188(4):1147-50. PMID: 17377060.
    View in: PubMed
  134. del Carmen MG, Findley M, Muzikansky A, Roche M, Verrill C, Horowitz NS, Seiden MV . A comparison of demographics, risk factors, and screening knowledge between Latino and non-Latino women referred for colposcopy. Gynecol Oncol. 2007; 104(1):70-76.
  135. del Carmen MG, Findley M, Muzikansky A, Roche M, Verrill CL, Horowitz N, Seiden MV. Demographic, risk factor, and knowledge differences between Latinas and non-Latinas referred to colposcopy. Gynecol Oncol. 2007 Jan; 104(1):70-6. PMID: 16949138.
    View in: PubMed
  136. del Carmen, Marcela. The Health and Human Rights of Nicaraguan Immigrants in Costa Rica. 2006.
  137. del Carmen MG, Bristow RE, Duska LR. Chapter 2: Preoperative preparation and surgical instrumentation. Surgery for ovarian cancer: principles and practice. Bristow, Karlan, editors. 2006; 3955.
  138. Rizvi I, del Carmen MG. Synergism of Epidermal Growth Factor Receptor-Targeted Immunotherapy with Photodynamic Treatment of Ovarian Cancer In Vivo. 2006.
  139. del Carmen MG. Primary epithelial ovarian cancer: diagnosis and management. American Society of Clinical Oncology. 2006 ASCO Educational Book. Editor, Michael C. Perry. 2006; 330-334.
  140. Rizvi I, del Carmen MG, Chang Y, Moor ACE, Oliva E, Sherwood M, Pogue B and Hasan T. Epidermal Growth Factor Receptor Targeted Immunotherapy is Synergistice with Photodynamic Treatment of Ovarian Cancer In Vivo. Poster. 2006.
  141. del Carmen MG, Rizvi I, Chang Y, Moor AC, Oliva E, Sherwood M, Pogue B, Hasan T. Synergism of epidermal growth factor receptor-targeted immunotherapy with photodynamic treatment of ovarian cancer in vivo. J Natl Cancer Inst. 2005 Oct 19; 97(20):1516-24. PMID: 16234565.
    View in: PubMed
  142. del Carmen MG, Joffe S. Informed consent for medical treatment and research: a review. Oncologist. 2005 Sep; 10(8):636-41. PMID: 16177288.
    View in: PubMed
  143. Garg R, del Carmen MG. Management of endometrial hyperplasia. Postgraduate Obstetrics and Gynecology. 2005; 25(1):1-5.
  144. Bristow RE, Zahurak ML, del Carmen MG, Gordon TA, Fox HE, Trimble EL, Montz FJ. Ovarian cancer surgery in Maryland: volume-based access to care. Gynecol Oncol. 2004 May; 93(2):353-60. PMID: 15099945.
    View in: PubMed
  145. del Carmen, MG. Primary squamous carcinoma of the uterine cervix: diagnosis and management. Postgraduate Obstetrics and Gynecology. 2004; 24(5):1-6.
  146. del Carmen MG, Bristow RE, Montz FJ. Chapter 45: Management of complications of surgery. Gynecologic cancer: controversies in management. Gershenson, Gore, McGuire, Quinn, Thomas, editors. 2004; 577-92.
  147. del Carmen MG. First-line chemotherapy for the treatment of epithelial ovarian cancer. Postgraduate Obstetrics and Gynecology. 2004; 24(9):1-6.
  148. del Carmen MG, Fuller AF, Matulonis U, Horick NK, Goodman A, Duska LR, Penson R, Campos S, Roche M, Seiden MV. Phase II trial of anastrozole in women with asymptomatic müllerian cancer. Gynecol Oncol. 2003 Dec; 91(3):596-602. PMID: 14675683.
    View in: PubMed
  149. Del Carmen MG, Smith Sehdev AE, Fader AN, Zahurak ML, Richardson M, Fruehauf JP, Montz FJ, Bristow RE. Endometriosis-associated ovarian carcinoma: differential expression of vascular endothelial growth factor and estrogen/progesterone receptors. Cancer. 2003 Oct 15; 98(8):1658-63. PMID: 14534882.
    View in: PubMed
  150. del Carmen MG, Eisner B, Willet CG, Fuller AF. Intraoperative radiation therapy in the management of gynecologic and genitourinary malignancies. Surg Oncol Clin N Am. 2003 Oct; 12(4):1031-42. PMID: 14989131.
    View in: PubMed
  151. Bristow RE, del Carmen MG, Kaufman HS, Montz FJ. Radical oophorectomy with primary stapled colorectal anastomosis for resection of locally advanced epithelial ovarian cancer. J Am Coll Surg. 2003 Oct; 197(4):565-74. PMID: 14522325.
    View in: PubMed
  152. Bristow RE, del Carmen MG, Pannu HK, Cohade C, Zahurak ML, Fishman EK, Wahl RL, Montz FJ. Clinically occult recurrent ovarian cancer: patient selection for secondary cytoreductive surgery using combined PET/CT. Gynecol Oncol. 2003 Sep; 90(3):519-28. PMID: 13678719.
    View in: PubMed
  153. del Carmen MG, Hughes KS, Halpern E, Rafferty E, Kopans D, Parisky YR, Sardi A, Esserman L, Rust S, Michaelson J. Racial differences in mammographic breast density. Cancer. 2003 Aug 01; 98(3):590-6. PMID: 12879477.
    View in: PubMed
  154. del Carmen MG, Lovett D, Goodman A. A case of Müllerian adenosarcoma of the uterus treated with liposomal doxorubicin. Gynecol Oncol. 2003 Mar; 88(3):456-8. PMID: 12648604.
    View in: PubMed
  155. 26. Montz FJ, Bristow RE, del Carmen MG. Chapter 37: Operative injuries to the ureter. TeLinde’s operative gynecology. Rock JA, Jones HW, editors. 2003; 1081-97.
  156. del Carmen MG. Diagnosis and management of epithelial ovarian carcinoma. Postgraduate Obstetrics and Gynecology. 2003; 23:1-8.
  157. Suh-Burgman E, Sivret J, Duska LR, del Carmen MG, Seiden MV. Long-term administration of intravaginal dehydroepiandrosterone on regression of low-grade cervical dysplasia: a pilot study. Gynecol Obstet Invest. 2003; 55:25-31.
  158. del Carmen MG, Bristow RE, Montz FJ. . Hormonal management of early endometrial cancer. Primary Care Updates for Ob/Gyns. 2003; 10(3):105-9.
  159. del Carmen MG. Hormone replacement therapy and cancer risk. Postgraduate Obstetrics and Gynecology. 2002; 22:1-6.
  160. Rizvi I, del Carmen MG, Moor AC, Dinh TA and Hasan T. Enhancement of Epidermal Growth Factor Receptor Targeted Treatment of Ovarian Cancer with Photodynamic Therapy. 2002.
  161. Moor ACE, del Carmen MG, Mulder K, Rivzi I, Yu W, Dinh T, Hasan T. A New Treatment Modality for Ovarian Cancer: Epidermal Growth Factor Receptor Targeted Therapy in Combination with Photodynamic Treatment. 2001.
  162. Hasan T, del Carmen MG, Dinh TA, Moor AC, Savellano M, Yu Wp, Mulder K, Rice W, Rizvi, I and Sharlin D. Epidermal Growth Factor Receptor: A Molecular Target in Photodynamic Therapy. 2001.
  163. del Carmen MG, McIntyre JF, Fuller AF, Nikrui N, Goodman A. Intraoperative radiation therapy in the treatment of pelvic gynecologic malignancies: a review of fifteen cases. Gynecol Oncol. 2000 Dec; 79(3):457-62. PMID: 11104619.
    View in: PubMed
  164. del Carmen, MG, Goodman AK. Management of the abnormal Pap smear. Postgraduate Obstetrics and Gynecology. 2000; 18:1-7.
  165. Moor AC, del Carmen MG, Rizvi I, Savellano M, Yu W and Hasan T. The EGF Receptor as Target for Photoimmunotherapy of Ovarian Cancer. 2000.
  166. del Carmen MG, McIntyre JF, Goodman A. The role of intraoperative radiation therapy (IORT) in the treatment of locally advanced gynecologic malignancies. Oncologist. 2000; 5(1):18-25. PMID: 10706646.
    View in: PubMed
  167. del Carmen MG, Goodman AK. Squamous cell carcinoma in situ of the uterine cervix. Postgraduate Obstetrics and Gynecology. 2000; 20:1-8.
  168. Moor AC, Rizvi I, Savellano M, Yu W, del Carmen MG and Hasan T. Photoimmunotargeting of the Epidermal Growth Factor Receptor for the Treatment of Ovarian Cancer. 2000.
  169. del Carmen MG, Montz FJ, Bristow RE, Bovicelli A, Cornelison T, Trimble E. Ethnic differences in patterns of care of stage 1A(1) and stage 1A(2) cervical cancer: a SEER database study. Gynecol Oncol. 1999 Oct; 75(1):113-7. PMID: 10502436.
    View in: PubMed
  170. del Carmen MG, Murphy J. Pubertal disorders. The Johns Hopkins Manual of Gynecology and Obstetrics (E. Wallach, Senior Editor). 1999; 312-9.
  171. Ghosh K, Morris M, del Carmen MG, Montz FJ. Epidemiological characteristics of noncompliant patients with cervical intraepithelial neoplasia in underserved areas. Journal of Lower Genital Tract Disease. 1999; 3:171-5.
  172. del Carmen MG, Murphy J. Sexual function and dysfunction. The Johns Hopkins Manual of Gynecology and Obstetrics (E. Wallach, Senior Editor). 1999; 300-8.
  173. del Carmen MG, Pizer E, Bristow RE, Montz FJ. . Microinvasive squamous carcinoma of the uterine cervix. Postgraduate Obstetrics and Gynecology. 1999; 19:1-8.
  174. Smith YR, Zubieta JK, del Carmen MG, Dannals RF, Ravert HT, Zacur HA, Frost JJ. Brain opioid receptor measurements by positron emission tomography in normal cycling women: relationship to luteinizing hormone pulsatility and gonadal steroid hormones. J Clin Endocrinol Metab. 1998 Dec; 83(12):4498-505. PMID: 9851799.
    View in: PubMed
  175. del carmen MG, Kurman R, Montz FJ. Hormonal treatment for early endometrial carcinoma. OBG Management. OBG Management. 1998; 85-98.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
del Carmen's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (375)
Explore
_
Co-Authors (67)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_